📖
Safety and pharmacokinetics of CL-197, a potent compound with low cytotoxicity against HIV-1: a randomized, double-blind, placebo-controlled, first-in-human phase 1 clinical trial.
Guo Y, Li Y, Zhao P, Bi J, Gou C, Chuai Z, Yu S, Zhang R, Du J, Ou Y, Xu R, Guo N, Wang F-S, Li Y

Safety and pharmacokinetics of CL-197, a potent compound with low cytotoxicity against HIV-1: a randomized, double-blind, placebo-controlled, first-in-human phase 1 clinical trial.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Antimicrob Agents Chemother.

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Safety and pharmacokinetics of CL-197, a potent compound with low cytotoxicity against HIV-1: a randomized, double-blind, placebo-controlled, first-in-human phase 1 clinical trial.
Author / Organization Guo Y, Li Y, Zhao P, Bi J, Gou C, Chuai Z, Yu S, Zhang R, Du J, Ou Y, Xu R, Guo N, Wang F-S, Li Y
Subject & Discipline Antimicrob Agents Chemother
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-68599
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »